Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Allay Health is a private digital health company focused on care delivery for patients with chronic gastrointestinal conditions, with an initial emphasis on inflammatory bowel disease. The company offers a technology-enabled platform intended to supplement episodic GI care with personalized support spanning nutrition, behavioral health, coaching, education, and patient community features. Based on public startup profiles, Allay Health was founded in 2021 in the Seattle/Bellevue, Washington area and appears to be operating as an early-stage private company rather than a drug developer. It is healthcare-related, but it does not appear to have a traditional therapeutic pipeline of biotech or pharmaceutical assets. Publicly available information suggests its business model is centered on digital chronic care management and patient engagement for GI populations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Allay Health.